908 Devices Inc.·4

Apr 10, 6:37 PM ET

Brown Christopher D. 4

Research Summary

AI-generated summary

Updated

908 Devices (MASS) Director Christopher D. Brown Sells Shares

What Happened Christopher D. Brown, a director of 908 Devices (MASS), sold a total of 40,000 shares in open-market transactions between April 8 and April 10, 2026, generating approximately $282,278 in proceeds. The sales broke down as: 15,030 shares on 2026-04-08 at a weighted avg $7.05 ($105,962); 7,392 shares on 2026-04-09 at $7.04 ($52,040); and 17,578 shares on 2026-04-10 at $7.07 ($124,276). These were disposals (sales), not purchases.

Key Details

  • Transaction dates and reported weighted-average prices:
    • 2026-04-08: 15,030 shares at $7.05 (proceeds ~$105,962)
    • 2026-04-09: 7,392 shares at $7.04 (proceeds ~$52,040)
    • 2026-04-10: 17,578 shares at $7.07 (proceeds ~$124,276)
  • Price ranges noted in filing:
    • 4/8 sales: multiple prices $7.00–$7.25 (F2; weighted avg reported)
    • 4/9 sales: multiple prices $7.00–$7.10 (F3)
    • 4/10 sales: multiple prices $7.00–$7.14 (F4)
    • The reporting person offers to provide a breakdown of shares sold at each price on request (per F2).
  • Plan/authorization: Trades were made pursuant to a Rule 10b5-1 trading plan adopted November 24, 2025 (F1).
  • Shares owned after transaction: not disclosed in the provided excerpt of the Form 4.
  • Filing timeliness: Form filed April 10, 2026 (period of report includes April 8); no late‑filing flag indicated.

Context Sales executed under a pre-established 10b5-1 plan are typically scheduled trades and are often treated as routine rather than a direct signal of the insider’s view on the company. For retail investors, purchases are generally more informative about insider sentiment than scheduled sales; these transactions simply record that a director liquidated a block of shares under an existing plan.